Additional file 1 of Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004–2018
Creators: name: Luo, Yizhe
name: Wu, Binxiong
name: Xu, Yameng
name: Ai, Lele
name: Lv, Heng
name: Wu, Jiahong
name: Tan, Weilong
Publisher: name: figshare
Year: 2024
Subjects: subject: Medicine
subject: Neuroscience
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy
subject: Mental Health
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Computational Biology

description: Additional file 1: Supplementary method. Joinpoint regression. Supplementary discussion. Table 1. The incidence of seven categories, total incidence and mortality of infectious diseases from 2004 to 2018, per 100,000. Table 2. Fifteen-year trends in incidence, number of cases, mortality and deaths of 44 notifiable infectious diseases in China, 2004-2018. Table 3. Changes in number of cases, incidence (per 100 000), number of deaths, and case-fatality ratios (per 1000) for 44 notifiable infectious diseases in China, 2004-2018. Table 4. The annual percentage changes (APC) and the joinpoint year range for 44 current notifiable infectious diseases in China from 2004 to 2018. Table 5. Incidence (per 100 000) of 44 infectious diseases stratified by age groups (years). Table 6. Incidence (per 100 000) of 44 infectious diseases stratified by gender. Table 7. Incidence (per 100 000) of 44 infectious diseases stratified by gender and transmission routes. Table 8. Incidence (per 100 000) of 44 infectious diseases stratified by gender and transmission routes. Fig. S1. The annual percentage changes (APC) and turning point in the trend from 2004 to 2018 for total and seven categories of infectious diseases using the joinpoint regression models. Fig. S2. Ranks of mortality or number of deaths for 44 notifiable infectious diseases during the past 15-years from 2004 to 2018. Fig. S3. The trends of incidence of each infectious disease in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018. Fig. S3-1. The trends of incidence of Haemorrhagic Fever in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-2. The trends of incidence of Cholera in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-3. The trends of incidence of Hepatitis B in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-4. The trends of incidence of NT in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-5. The trends of incidence of SI in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-6. The trends of incidence of Mumps in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-7. The trends of incidence of Hepatitis A in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-8. The trends of incidence of Pertussis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-9. The trends of incidence of Rubella in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-10. The trends of incidence of Measles in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-11. The trends of incidence of T/P in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-12. The trends of incidence of OID in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-13. The trends of incidence of AHC in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-14. The trends of incidence of Dysentery in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-15. The trends of incidence of JE in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-16. The trends of incidence of Typhus in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-17. The trends of incidence of Malaria in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-18. The trends of incidence of Schistosomiasis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-19. The trends of incidence of Dengue in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-20. The trends of incidence of Kala-azar in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-21. The trends of incidence of Hydatid disease in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-22. The trends of incidence of Brucellosis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-23. The trends of incidence of Hepatitis E in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-24. The trends of incidence of Anthrax in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-25. The trends of incidence of Rabies in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-26. The trends of incidence of Leptospirosis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-27. The trends of incidence of Scarlet fever in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-28. The trends of incidence of Tuberculosis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-29. The trends of incidence of Meningococcal meningitis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-30. The trends of incidence of Leprosy in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-31. The trends of incidence of Hepatitis C in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-32. The trends of incidence of Syphilis in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-33. The trends of incidence of Gonorrhoea in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S3-34. The trends of incidence of HIV/AIDS in both genders and its joinpoint(s) during the past 15-years from 2004 to 2018 (* represented the statistical significant trends. Legends were the same to Fig S1). Fig. S4. The comparison of incidence of 44 current notifiable infectious diseases in boys or males and girls or females from 2004 to 2018 (using the chi-square test). Fig. S5. Trends in age incidence rates for each infectious disease in females and males, from 2004 to 2018. Fig. S5-1. Trends in age incidence rates for Haemorrhagic Fever, females and males, 2004-2018. Fig. S5-2. Trends in age incidence rates for Cholera, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-3. Trends in age incidence rates for Plague, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig S5-4. Trends in age incidence rates for Hepatitis D, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-5. Trends in age incidence rates for Hepatitis B, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-6. Trends in age incidence rates for NT, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-7. Trends in age incidence rates for Seasonal Influenza, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-8. Trends in age incidence rates for Mumps, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-9. Trends in age incidence rates for Hepatitis A, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig S5-10. Trends in age incidence rates for Diphtheria, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-11. Trends in age incidence rates for Pertussis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-12. Trends in age incidence rates for Poliomyelitis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-13. Trends in age incidence rates for Rubella, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-14. Trends in age incidence rates for Measles, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-15. Trends in age incidence rates for Typhoid and paratyphoid, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-16. Trends in age incidence rates for Infectious diarrhoea, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-17. Trends in age incidence rates for Acute haemorrhagic conjunctivitis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-18. Trends in age incidence rates for Hand, foot, and mouth disease, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-19. Trends in age incidence rates for Dysentery, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-20. Trends in age incidence rates for Japanese encephalitis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-21. Trends in age incidence rates for Typhus, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-22. Trends in age incidence rates for Malaria, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-23. Trends in age incidence rates for Schistosomiasis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-24. Trends in age incidence rates for Filariasis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-25. Trends in age incidence rates for Dengue, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-26. Trends in age incidence rates for Kala−azar, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-27. Trends in age incidence rates for H5N1, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-28. Trends in age incidence rates for H7N9, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-29. Trends in age incidence rates for Hydatid disease, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-30. Trends in age incidence rates for Brucellosis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-31. Trends in age incidence rates for Hepatitis E, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-32. Trends in age incidence rates for Anthrax, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-33. Trends in age incidence rates for Rabies, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-34. Trends in age incidence rates for H1N1, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-35. Trends in age incidence rates for Leptospirosis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-36. Trends in age incidence rates for SARS, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-37. Trends in age incidence rates for Scarlet fever, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-38. Trends in age incidence rates for Tuberculosis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-39. Trends in age incidence rates for Meningococcal meningitis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-40. Trends in age incidence rates for Leprosy, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-41. Trends in age incidence rates for Hepatitis C, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-42. Trends in age incidence rates for Syphilis, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-43. Trends in age incidence rates for Gonorrhoea, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S5-44. Trends in age incidence rates for HIV/AIDS, females and males, 2004-2018 (Legends were the same to Fig S5-1). Fig. S6. The seasonal variation by month of seven categories of 44 notifiable infectious diseases from 2004 to 2018.